Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Plant Health Care plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

√

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Gartmore Investment Limited

4. Full name of shareholder(s)  (if different from 3.):iv

HSBC Global Custody Nominee UK Ltd (1.760%)

Nortrust Nominees Limited (2.786%)

Gartmore Growth Opportunities (0.563%)

Goldman Sachs Nominees Ltd (1.659%)

Vidacos Nominees Ltd A/C 2303(5.357%)

5. Date of the transaction and date on which the threshold is crossed or reached: v

5 July 2010

6. Date on which issuer notified:

6 July 2010

7. Threshold(s) that is/are crossed or reached: vi, vii

12%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B01JC540

6,118,868

6,118,868

6,399,305

6,399,305

12.124%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,399,305

12.124%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

All figures are based on the Company's issued share capital of 52,783,680 as provided by Exshare

E mail contact [email protected]

14. Contact name:

(i) Andrew Wood FCIS, Company Secretary

(II) Tim Redfern, Evolution Securities Limited

(iii) Jeremy Carey, Tavistock Communications

15. Contact telephone number:

(i) +44 (0)20 8866 5702

(ii) +44 (0)20 7071 4300

(iii) +44 (0)20 7920 3150

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

Gartmore Investment Limited

Contact address

(registered office for legal entities)

Gartmore House, 8 Fenchurch Place, London EC2M 4PB

Phone number & email

0207 782 2224

Other useful information

(at least legal representative for legal persons)

Gavin Clark

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.